A Study of LY900014 in Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2017-12-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare LY900014 with insulin lispro (Humalog) in
participants with type 2 diabetes mellitus. The study will be conducted in participants with
type 2 diabetes on insulin injection therapy to investigate how the body processes LY900014
and the effect of LY900014 on blood sugar levels compared to insulin lispro (Humalog).
Screening is required within 28 days prior to the start of the study. For each participant,
the total duration of the clinical trial will be between 3 and 8 weeks.